1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Lithuania Pharmaceuticals and Healthcare Report Q1 2016

Lithuania Pharmaceuticals and Healthcare Report Q1 2016

  • January 2016
  • -
  • Business Monitor International
  • -
  • 78 pages

BMI View: Lithuania's pharmaceutical and healthcare market represents a modest prospect for investmentfrom multinational firms. Increasing demand due to a rising burden of chronic disease will translate to anincrease in sales; however, fiscal policies and the small size of the market will limit revenue earningopportunities.

Headline Expenditure Projections

- Pharmaceuticals: EUR601mn (USD806mn) in 2014 to EUR616mn (USD677mn) in 2015; +2.4% inlocal currency terms and -16.0% in US dollar terms. Forecast revised downwards from Q215.

- Healthcare: EUR2.14bn (USD2.87bn) in 2014 to EUR2.14bn (USD2.36bn) in 2015; +0.1% in localcurrency terms and -17.8% in US dollar terms. Forecast revised downwards from Q215.

Table Of Contents

Lithuania Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Lithuania 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Lithuania 2013-2019) 12
Healthcare Market Forecast 13
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Lithuania 2013-2019) 15
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Lithuania 2013-2019) 15
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Lithuania 2013-2019) 15
Prescription Drug Market Forecast 16
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Lithuania 2011-2019) 17
Patented Drug Market Forecast 18
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Lithuania 2011-2019) 19
Generic Drug Market Forecast 20
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Lithuania 2013-2019) 21
OTC Market Forecast 22
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Lithuania 2013-2019) 23
Pharmaceutical Trade Forecast 24
Table: Pharmaceutical Trade Data And Forecasts (Lithuania 2013-2019) 25
Table: Pharmaceutical Trade Data And Forecasts local currency (Lithuania 2013-2019) 26
Industry Risk Reward Index 27
Central And Eastern Europe Risk/Reward Index - Q1 2016 27
Lithuania Risk/Reward Index 34
Rewards 34
Risks 34
Regulatory Review 36
Intellectual Property Regime 39
Pricing Regime 39
Table: Wholesale Mark-Ups For Reimbursed And Non-Reimbursed Medicines 40
Reimbursement Regime 41
Table: Retail Mark-Ups For Reimbursed And Non-Reimbursed Medicines 42
Market Overview 44
Healthcare Sector 45
Table: Healthcare Resources (Lithuania 2009-2014) 46
Table: Healthcare Personnel (Lithuania 2009-2014) 46
Table: Healthcare Activity (Lithuania 2009-2014) 47
Research and Development 48
Clinical Trials 50
Epidemiology 51
Table: Leading Causes of Death, 2005-2013 51
Table: Incidence of HIV and AIDS, 2002-2010 53
Competitive Landscape 54
Research-Based Industry 54
Table: Members of the Innovative Pharmaceutical Industry Association (IFPA) 54
Table: Multinational Market Activity 55
Generic Drugmakers 55
Pharmaceutical Distribution 56
Pharmaceutical Retail Sector 57
Company Profile 59
Valentis 59
Sanitas (Valeant) 61
Sicor Biotech (Teva) 64
Demographic Forecast 67
Table: Population Headline Indicators (Lithuania 1990-2025) 68
Table: Key Population Ratios (Lithuania 1990-2025) 68
Table: Urban/Rural Population and Life Expectancy (Lithuania 1990-2025) 69
Table: Population By Age Group (Lithuania 1990-2025) 69
Table: Population By Age Group % (Lithuania 1990-2025) 70
Glossary 72
Methodology 74
Pharmaceutical Expenditure Forecast Model 74
Healthcare Expenditure Forecast Model 74
Notes On Methodology 75
Risk/Reward Index Methodology 76
Index Overview 77
Table: Pharmaceutical Risk/Reward Index Indicators 77
Indicator Weightings 78

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.